These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27731495)

  • 1. Inactivation and removal of Zika virus during manufacture of plasma-derived medicinal products.
    Blümel J; Musso D; Teitz S; Miyabayashi T; Boller K; Schnierle BS; Baylis SA
    Transfusion; 2017 Mar; 57(3pt2):790-796. PubMed ID: 27731495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of Zika virus by solvent/detergent treatment of human plasma and other plasma-derived products and pasteurization of human serum albumin.
    Kühnel D; Müller S; Pichotta A; Radomski KU; Volk A; Schmidt T
    Transfusion; 2017 Mar; 57(3pt2):802-810. PubMed ID: 28019034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of Zika virus in plasma and derivatives by four different methods.
    Wang Y; Ren K; Liao X; Luo G; Kumthip K; Leetrakool N; Li S; Chen L; Yang C; Chen Y
    J Med Virol; 2019 Dec; 91(12):2059-2065. PubMed ID: 31389019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zika virus is not thermostable: very effective virus inactivation during heat treatment (pasteurization) of human serum albumin.
    Farcet MR; Kreil TR
    Transfusion; 2017 Mar; 57(3pt2):797-801. PubMed ID: 27987206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination.
    Santa Maria F; Laughhunn A; Lanteri MC; Aubry M; Musso D; Stassinopoulos A
    Transfusion; 2017 Aug; 57(8):2016-2025. PubMed ID: 28671343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Watterson D; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Faddy HM
    Transfusion; 2017 Nov; 57(11):2677-2682. PubMed ID: 28718518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amustaline (S-303) treatment inactivates high levels of Zika virus in red blood cell components.
    Laughhunn A; Santa Maria F; Broult J; Lanteri MC; Stassinopoulos A; Musso D; Aubry M
    Transfusion; 2017 Mar; 57(3pt2):779-789. PubMed ID: 28164306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles.
    Albulescu IC; Kovacikova K; Tas A; Snijder EJ; van Hemert MJ
    Antiviral Res; 2017 Jul; 143():230-236. PubMed ID: 28461070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysulfonate suramin inhibits Zika virus infection.
    Tan CW; Sam IC; Chong WL; Lee VS; Chan YF
    Antiviral Res; 2017 Jul; 143():186-194. PubMed ID: 28457855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination.
    Aubry M; Richard V; Green J; Broult J; Musso D
    Transfusion; 2016 Jan; 56(1):33-40. PubMed ID: 26283013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterization of Zika virus RNA reference reagents as a response to a public health emergency.
    Fares-Gusmao R; Chancey C; Volkova E; Grinev A; Sippert E; Jiang Z; Rios M
    Transfusion; 2018 Sep; 58(9):2171-2174. PubMed ID: 30178463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordination of different ligands to copper(II) and cobalt(III) metal centers enhances Zika virus and dengue virus loads in both arthropod cells and human keratinocytes.
    Dutta S; Celestine MJ; Khanal S; Huddleston A; Simms C; Arca JF; Mitra A; Heller L; Kraj PJ; Ledizet M; Anderson JF; Neelakanta G; Holder AA; Sultana H
    Biochim Biophys Acta Gen Subj; 2018 Jan; 1862(1):40-50. PubMed ID: 29030319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zika virus-like particle (VLP) based vaccine.
    Boigard H; Alimova A; Martin GR; Katz A; Gottlieb P; Galarza JM
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005608. PubMed ID: 28481898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus.
    Wang Q; Yang H; Liu X; Dai L; Ma T; Qi J; Wong G; Peng R; Liu S; Li J; Li S; Song J; Liu J; He J; Yuan H; Xiong Y; Liao Y; Li J; Yang J; Tong Z; Griffin BD; Bi Y; Liang M; Xu X; Qin C; Cheng G; Zhang X; Wang P; Qiu X; Kobinger G; Shi Y; Yan J; Gao GF
    Sci Transl Med; 2016 Dec; 8(369):369ra179. PubMed ID: 27974667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectivity of Zika virus on primary cells support tree shrew as animal model.
    Zhang L; Shen ZL; Feng Y; Li DQ; Zhang NN; Deng YQ; Qi XP; Sun XM; Dai JJ; Yang CG; Yang ZF; Qin CF; Xia XS
    Emerg Microbes Infect; 2019; 8(1):232-241. PubMed ID: 30866776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and sexual transmission of Spondweni and Zika viruses.
    McDonald EM; Duggal NK; Brault AC
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005990. PubMed ID: 28985234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Culex Species Mosquitoes and Zika Virus.
    Huang YJ; Ayers VB; Lyons AC; Unlu I; Alto BW; Cohnstaedt LW; Higgs S; Vanlandingham DL
    Vector Borne Zoonotic Dis; 2016 Oct; 16(10):673-6. PubMed ID: 27556838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H5N1 influenza virus and the safety of plasma products.
    Kreil TR; Unger U; Orth SM; Petutschnig G; Kistner O; Poelsler G; Berting A
    Transfusion; 2007 Mar; 47(3):452-9. PubMed ID: 17319825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of dengue virus in the plasma-derived therapeutic proteins.
    Xie YW; Chan PK; Szeto CK; Kwok SY; Chu IM; Chu SS; Cheung JL; Wong SW; Ali MB; Wong BL
    Transfusion; 2008 Jul; 48(7):1342-7. PubMed ID: 18315529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis E virus derived from different sources exhibits different behaviour in virus inactivation and/or removal studies with plasma derivatives.
    Yunoki M; Tanaka H; Takahashi K; Urayama T; Hattori S; Ideno S; Furuki R; Sakai K; Hagiwara K; Ikuta K
    Biologicals; 2016 Sep; 44(5):403-11. PubMed ID: 27461242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.